News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,350 Results
Type
Article (41501)
Company Profile (460)
Press Release (656389)
Section
Business (208344)
Career Advice (1999)
Deals (35935)
Drug Delivery (90)
Drug Development (83262)
Employer Resources (169)
FDA (16322)
Job Trends (15037)
News (351989)
Policy (32972)
Tag
Academia (2619)
Alliances (50557)
Alzheimer's disease (1253)
Approvals (16234)
Artificial intelligence (121)
Bankruptcy (361)
Best Places to Work (11654)
Biotechnology (345)
Breast cancer (104)
Cancer (906)
Career advice (1670)
Cell therapy (205)
Clinical research (65621)
Collaboration (334)
Compensation (157)
COVID-19 (2580)
Cystic fibrosis (82)
Data (839)
Diabetes (130)
Diagnostics (6147)
Drug pricing (83)
Earnings (85276)
Employer resources (146)
Events (112160)
Executive appointments (243)
FDA (16751)
Funding (294)
Gene therapy (161)
GLP-1 (587)
Government (4401)
Healthcare (18972)
Infectious disease (2652)
Inflammatory bowel disease (107)
Interviews (308)
IPO (16539)
Job creations (3693)
Job search strategy (1427)
Layoffs (434)
Legal (7922)
Lung cancer (157)
Manufacturing (149)
Medical device (13284)
Medtech (13289)
Mergers & acquisitions (19389)
Metabolic disorders (368)
Neuroscience (1501)
NextGen Class of 2024 (6727)
Non-profit (4530)
Northern California (1178)
Obesity (220)
Opinion (194)
Patents (94)
People (57451)
Pharmaceutical (86)
Phase I (20538)
Phase II (28952)
Phase III (21449)
Pipeline (202)
Postmarket research (2590)
Preclinical (8811)
Radiopharmaceuticals (250)
Rare diseases (192)
Real estate (5996)
Regulatory (21859)
Research institute (2402)
Resumes & cover letters (351)
Southern California (1070)
Startups (3745)
United States (11721)
Vaccines (549)
Weight loss (169)
Date
Today (180)
Last 7 days (852)
Last 30 days (2993)
Last 365 days (37078)
2024 (30923)
2023 (41013)
2022 (52276)
2021 (56765)
2020 (54924)
2019 (47419)
2018 (35697)
2017 (33025)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29221)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (194)
Asia (38380)
Australia (6378)
California (2727)
Canada (1159)
China (208)
Colorado (116)
Connecticut (124)
Europe (83657)
Florida (381)
Georgia (96)
Illinois (318)
Indiana (178)
Kansas (98)
Maryland (518)
Massachusetts (2253)
Michigan (144)
Minnesota (252)
New Jersey (817)
New York (829)
North Carolina (712)
Northern California (1178)
Ohio (124)
Pennsylvania (741)
South America (1105)
Southern California (1070)
Texas (380)
Washington State (327)
698,350 Results for "serina therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
Serina Therapeutics, Inc., a clinical-stage biotechnology company focused on developing its proprietary POZ PlatformTM drug delivery technology announced the appointment of Dr. Simba Gill as Executive Chairman.
April 17, 2024
·
4 min read
Press Releases
Serina Therapeutics to Present at the 14th Annual Injectables Summit
October 2, 2024
·
3 min read
BioMidwest
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
Enable Injections, Inc. and Serina Therapeutics announced a partnership to develop and commercialize SER-252 in combination with enFuse for the treatment of Parkinson’s disease.
May 15, 2024
·
6 min read
Deals
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Serina Therapeutics (NYSE American: SER), a clinical-stage biotechnology company developing a pipeline of therapies for the treatment of Parkinson’s Disease and other neurological diseases, today announced the closing of its previously announced merger with a wholly-owned subsidiary of AgeX Therapeutics, Inc.
March 26, 2024
·
12 min read
Business
Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
Serina Therapeutics, a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, reported financial results for the quarter ended March 31, 2024 and provided business highlights.
May 14, 2024
·
11 min read
Business
Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer
Serina Therapeutics, Inc. today announced Serina has entered into a License Agreement under which Pfizer Inc. will license, on a non-exclusive basis, Serina’s POZ polymer technology.
November 17, 2023
·
6 min read
Press Releases
Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 5, 2024
·
1 min read
Press Releases
Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
August 12, 2024
·
14 min read
Press Releases
Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation
July 19, 2024
·
4 min read
Deals
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
Serina Therapeutics, Inc., a privately-held, clinical-stage biotechnology company developing a pipeline of therapies for the treatment of Parkinson’s Disease and other neurological diseases, entered into a merger agreement with AgeX Therapeutics, Inc. on August 29, 2023, under which Serina will merge with a wholly-owned subsidiary of AgeX in an all-stock transaction.
August 30, 2023
·
16 min read
1 of 69,835
Next
